2021-09 |
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
Cancers
|
2021-09 |
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2021-08 |
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy |
HEPATOLOGY INTERNATIONAL
|
2021-07 |
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus & ndash;related hepatocellular carcinoma |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
2021-07 |
Pharmacokinetics and safety of evogliptin in hepatically impaired patients |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
2021-07 |
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
DIGESTIVE DISEASES AND SCIENCES
|
2021-07 |
Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease |
LIVER INTERNATIONAL
|
2021-06 |
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models |
CELL DEATH & DISEASE
|
2021-06 |
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2021-06 |
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2021-06 |
External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals |
JOURNAL OF VIRAL HEPATITIS
|
2021-05 |
Hepatitis B Core-Related Antigen: From Virology to Clinical Application |
SEMINARS IN LIVER DISEASE
|
2021-05 |
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2021-05 |
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma |
GUT AND LIVER
|
2021-05 |
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B |
Journal of Hepatocellular Carcinoma
|
2021-04 |
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial |
Clinical and molecular hepatology
|
2021-04 |
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
2021-04 |
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
2021-04 |
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B |
Clinical and molecular hepatology
|
2021-04 |
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B |
HEPATOLOGY RESEARCH
|
2021-03 |
Artificial intelligence in liver disease |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2021-03 |
A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer |
Journal of liver cancer (대한간암학회지)
|
2021-03 |
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma |
CANCER INVESTIGATION
|
2021-02 |
Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression |
Clinical and Translational Gastroenterology
|
2021-02 |
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization |
Current Oncology
|
2021-02 |
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
2021-01 |
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
2021-01 |
Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2021-01 |
Hepatitis B Virus Cure: Targets and Future Therapies |
International Journal of Molecular Sciences
|
2021-01 |
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study |
Clinical and molecular hepatology
|
2021-01 |
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance |
Clinical and Translational Gastroenterology
|
2021-01 |
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy |
GUT AND LIVER
|
2021-01 |
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma |
YONSEI MEDICAL JOURNAL
|
2021-01 |
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir |
JOURNAL OF VIRAL HEPATITIS
|
2020-12 |
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy |
JOURNAL OF VIRAL HEPATITIS
|
2020-12 |
Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2020-12 |
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion |
Journal of hepatocellular carcinoma
|
2020-12 |
Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-12 |
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study |
GUT
|
2020-11 |
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
2020-11 |
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization |
GUT AND LIVER
|
2020-11 |
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals |
Cancers
|
2020-11 |
High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis |
JOURNAL OF VIRAL HEPATITIS
|
2020-11 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B |
DIGESTIVE AND LIVER DISEASE
|
2020-09 |
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack |
CEREBROVASCULAR DISEASES
|
2020-09 |
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) |
HEPATOLOGY INTERNATIONAL
|
2020-09 |
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2020-09 |
Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus |
GUT AND LIVER
|
2020-09 |
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma |
JOURNAL OF VIRAL HEPATITIS
|
2020-09 |
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation |
Cancers
|
2020-08 |
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
2020-08 |
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement |
LANCET GASTROENTEROLOGY & HEPATOLOGY
|
2020-07 |
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement |
JOURNAL OF HEPATOLOGY
|
2020-07 |
An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia |
LIVER INTERNATIONAL
|
2020-07 |
RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection |
HEPATOLOGY
|
2020-07 |
Entecavir plus tenofovir vs. lamivudine/telbivudine plus adefovir in chronic hepatitis B patients with prior suboptimal response |
Clinical and molecular hepatology
|
2020-07 |
IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses |
JOURNAL OF HEPATOLOGY
|
2020-07 |
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study |
GUT AND LIVER
|
2020-07 |
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
2020-06 |
How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease? |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2020-06 |
Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-05 |
Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C |
GUT AND LIVER
|
2020-05 |
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study |
LANCET GASTROENTEROLOGY & HEPATOLOGY
|
2020-05 |
Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
2020-05 |
Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib forAdvanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
2020-04 |
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea |
PLOS ONE
|
2020-04 |
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
2020-03 |
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-03 |
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase |
Clinical and Translational Gastroenterology
|
2020-03 |
An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate |
JOURNAL OF VIRAL HEPATITIS
|
2020-03 |
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2020-02 |
HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines |
JOURNAL OF CANCER
|
2020-01 |
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea |
Clinical and molecular hepatology
|
2020-01 |
Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: A multicenter study |
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
|
2020-01 |
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection |
Clinical and molecular hepatology
|
2020-01 |
Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study |
MODERN RHEUMATOLOGY
|
2020-01 |
Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2019-12 |
Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy |
SCIENTIFIC REPORTS
|
2019-12 |
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis |
DIGESTIVE DISEASES AND SCIENCES
|
2019-12 |
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B |
Clinical and molecular hepatology
|
2019-12 |
Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2019-12 |
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2019-11 |
The remaining challenges of HCV treatment in the direct-acting antivirals era |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2019-10 |
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis |
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
|
2019-09 |
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir |
Clinical and molecular hepatology
|
2019-09 |
External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy |
LIVER INTERNATIONAL
|
2019-09 |
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation |
CANCER MEDICINE
|
2019-09 |
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea |
JOURNAL OF HEPATOLOGY
|
2019-08 |
Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells |
JOURNAL OF HEPATOLOGY
|